Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Ovid Therapeutics Inc (OVID)

Ovid Therapeutics Inc (OVID)
0.6175 x 1 0.6600 x 5
Pre-market by (Cboe BZX)
0.6175 +0.0505 (+8.91%) 02/21/25 [NASDAQ]
0.6175 x 1 0.6600 x 5
Pre-market 0.5989 -0.0186 (-3.01%) 04:04 ET
Quote Overview for Fri, Feb 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.5671
Day High
0.6488
Open 0.5700
Previous Close 0.5670 0.5670
Volume 578,200 578,200
Avg Vol 470,795 470,795
Stochastic %K 16.02% 16.02%
Weighted Alpha -55.62 -55.62
5-Day Change -0.0282 (-4.37%) -0.0282 (-4.37%)
52-Week Range 0.5603 - 3.7912 0.5603 - 3.7912
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,849
  • Shares Outstanding, K 71,010
  • Annual Sales, $ 390 K
  • Annual Income, $ -52,340 K
  • EBIT $ -69 M
  • EBITDA $ -68 M
  • 60-Month Beta 0.30
  • Price/Sales 69.23
  • Price/Cash Flow N/A
  • Price/Book 0.53
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.47
  • Most Recent Earnings $-0.20 on 11/12/24
  • Next Earnings Date 03/14/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 203.74% ( -314.21%)
  • Historical Volatility 72.40%
  • IV Percentile 32%
  • IV Rank 17.63%
  • IV High 886.82% on 01/23/25
  • IV Low 57.55% on 03/19/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 253
  • Volume Avg (30-Day) 69
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 1,217
  • Open Int (30-Day) 911

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.16
  • Number of Estimates 6
  • High Estimate -0.15
  • Low Estimate -0.17
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5603 +10.21%
on 02/20/25
Period Open: 0.6982
0.8079 -23.57%
on 01/29/25
-0.0807 (-11.56%)
since 01/21/25
3-Month
0.5603 +10.21%
on 02/20/25
Period Open: 1.0600
1.2200 -49.39%
on 12/10/24
-0.4425 (-41.75%)
since 11/21/24
52-Week
0.5603 +10.21%
on 02/20/25
Period Open: 3.5700
3.7912 -83.71%
on 02/26/24
-2.9525 (-82.70%)
since 02/21/24

Most Recent Stories

More News
Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

OVID : 0.6175 (+8.91%)
Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting

OVID : 0.6175 (+8.91%)
Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results

OVID : 0.6175 (+8.91%)
Ovid Therapeutics to Host Investor Event

OVID : 0.6175 (+8.91%)
3 'Strong Buy'-Rated Stocks to Buy Now on the Dip

These outstanding growth stocks are worth buying on the dip.

AMZN : 216.58 (-2.83%)
$SPX : 6,013.13 (-1.71%)
GEHC : 91.09 (-1.09%)
GD : 243.06 (-1.28%)
OVID : 0.6175 (+8.91%)
TAK : 14.06 (+1.44%)
Ovid Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights

Anticipates filing an Investigational New Drug application for OV329, a potent GABA-aminotransferase inhibitor, and initiating a Phase 1 trial in the...

OVID : 0.6175 (+8.91%)
Ovid Therapeutics Presents Preclinical Data on OV329 at the Epilepsy Foundation Pipeline Conference

OV329 demonstrated robust anti-seizure activity in multiple preclinical seizure and epilepsy models, including treatment-resistant seizuresData demonstrate...

OVID : 0.6175 (+8.91%)
Ovid Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights

Ovid anticipates filing an investigational new drug application (IND) for OV329, a potent GABA aminotransferase inhibitor, and initiating Phase 1 trials in...

OVID : 0.6175 (+8.91%)
Ovid Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that...

OVID : 0.6175 (+8.91%)
Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial Results

Ovid executing on its strategy to build a leading epilepsy pipelineOV329 expected to enter the clinic in 2022Organization reshaped to reduce personnel by...

OVID : 0.6175 (+8.91%)

Business Summary

Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders. The company's product pipeline consists of OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. It also involved...

See More

Key Turning Points

3rd Resistance Point 0.7369
2nd Resistance Point 0.6928
1st Resistance Point 0.6552
Last Price 0.6175
1st Support Level 0.5735
2nd Support Level 0.5294
3rd Support Level 0.4918

See More

52-Week High 3.7912
Fibonacci 61.8% 2.5570
Fibonacci 50% 2.1758
Fibonacci 38.2% 1.7945
Last Price 0.6175
52-Week Low 0.5603

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements